Nisha Suyien Chandran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nisha Suyien Chandran has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Ellie Choi
Division of Dermatology, Department of Medicine, National University Hospital, Singapore, Singapore
8 shared publications - Valencia Long
Department of Dermatology, Changi General Hospital , Singapore
4 shared publications Adinia Santosa
Division of Dermatology, Department of Medicine, National University Hospital, Singapore, Singapore
2 shared publications- Brian Kirby
St. Vincent's University Hospital, Elm Park Dublin Ireland
2 shared publications - Christopher John Sayed
Department of Dermatology, University of North Carolina, Chapel Hill, NC, USA
2 shared publications - Enno Schmidt
Institute of Experimental Dermatology, University of Lübeck, Lübeck, Germany
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 23 January 2025
- Published by Elsevier in Cytotherapy
- Vol. 27 (5) , 633-641
A phase 1, open-label study to determine safety and tolerability of the topical application of mesenchymal stem/stromal cell (MSC) exosome ointment to treat psoriasis in healthy volunteers
- 23 January 2025
- Published by Elsevier in Cytotherapy
- Vol. 27 (5) , 633-641
Top Cited PapersOpen AccessA phase 1, open-label study to determine safety and tolerability of the topical application of mesenchymal stem/stromal cell (MSC) exosome ointment to treat psoriasis in healthy volunteers
- Top Cited PapersOpen Access
Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies
Introduction: Herpes zoster is caused by the reactivation of latent varicella infection within the sensory ganglia, caused by the varicella-zoster virus (VZV). The disease is classically characterized by a painful unilateral vesicular eruption. Complications of the disease include herpes zoster ophthalmicus, Ramsay Hunt syndrome, acute retinal necrosis, and post-herpetic neuralgia. In this paper, we discuss the epidemiology, pathogenesis, clinical features, diagnosis, management, and vaccination strategies of herpes zoster and post-herpetic neuralgia. Method: This paper was developed with input from specialists from Singapore’s public sectors—dermatologists, family physicians, and infectious diseases specialists. Results: The diagnosis of herpes zoster is clinical and can be aided with laboratory investigations. Early initiation of antivirals, within 72 h of onset, can reduce the severity and duration of the condition and decrease the intensity of pain. In patients with a high risk of post-herpetic neuralgia, early initiation of anticonvulsants or tricyclic antidepressants can be considered. Herpes zoster is highly preventable, with the advent of the recombinant zoster vaccine (RZV) providing an overall vaccine efficacy of 97.2%. Procedures such as epidural blocks and subcutaneous or intracutaneous injections of local anesthetics and steroids can be considered for patients with a high risk of post-herpetic neuralgia to reduce its incidence. Conclusion: This article serves as a guideline for clinicians in the diagnosis, investigations, management, and prevention of herpes zoster. With the majority of adults in Singapore currently at risk of developing herpes zoster due to varicella immunization being only introduced in 2020, it is important for clinicians to recognize and manage herpes zoster appropriately.
Top Cited PapersOpen AccessHerpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies
Introduction: Herpes zoster is caused by the reactivation of latent varicella infection within the sensory ganglia, caused by the varicella-zoster virus (VZV). The disease is classically characterized by a painful unilateral vesicular eruption. Complications of the disease include herpes zoster ophthalmicus, Ramsay Hunt syndrome, acute retinal necrosis, and post-herpetic neuralgia. In this paper, we discuss the epidemiology, pathogenesis, clinical features, diagnosis, management, and vaccination strategies of herpes zoster and post-herpetic neuralgia. Method: This paper was developed with input from specialists from Singapore’s public sectors—dermatologists, family physicians, and infectious diseases specialists. Results: The diagnosis of herpes zoster is clinical and can be aided with laboratory investigations. Early initiation of antivirals, within 72 h of onset, can reduce the severity and duration of the condition and decrease the intensity of pain. In patients with a high risk of post-herpetic neuralgia, early initiation of anticonvulsants or tricyclic antidepressants can be considered. Herpes zoster is highly preventable, with the advent of the recombinant zoster vaccine (RZV) providing an overall vaccine efficacy of 97.2%. Procedures such as epidural blocks and subcutaneous or intracutaneous injections of local anesthetics and steroids can be considered for patients with a high risk of post-herpetic neuralgia to reduce its incidence. Conclusion: This article serves as a guideline for clinicians in the diagnosis, investigations, management, and prevention of herpes zoster. With the majority of adults in Singapore currently at risk of developing herpes zoster due to varicella immunization being only introduced in 2020, it is important for clinicians to recognize and manage herpes zoster appropriately.
- 18 June 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (1) , 50-55
Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue Specimens
- 18 June 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 145 (1) , 50-55
Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue Specimens
- 17 November 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 190 (4) , 510-518
Global consensus process to establish a core dataset for hidradenitis suppurativa registries
Background: Several registries for hidradenitis suppurativa (HS) already exist in Europe and the USA. There is currently no global consensus on a core dataset (CDS) for these registries. Creating a global HS registry is challenging, owing to logistical and regulatory constraints, which could limit opportunities for global collaboration as a result of differences in the dataset collected. The solution is to encourage all HS registries to collect the same CDS of information, allowing registries to collaborate. Objectives: To establish a core set of items to be collected by all HS registries globally. The core set will cover demographic details, comorbidities, clinical examination findings, patient-reported outcome measures and treatments. Methods: Beginning in September 2022, 20 participants – including both clinicians with expertise in HS and patient advocates – from eight countries across three continents participated in a Delphi process consisting of four rounds of voting, with all participants completing each round. A list of potential items for inclusion in the core set was generated from the relevant published literature, including systematic reviews of comorbidities in HS, clinical and examination findings, and epidemiology. For disease severity and progression items, the Hidradenitis SuppuraTiva Core outcome set International Collaboration (HiSTORIC) core set and other relevant instruments were considered for inclusion. This resulted in 47 initial items. Participants were invited to suggest additional items to include during the first round. Anonymous feedback was provided to inform each subsequent round of voting to encourage consensus. Results: The eDelphi process established a CDS of 48 items recommended for inclusion in all HS registries globally. Conclusions: The routine adoption of this CDS in current and future HS registries should allow registries in different parts of the world to collaborate, enabling research requiring large numbers of participants.
- 17 November 2023
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 190 (4) , 510-518
Global consensus process to establish a core dataset for hidradenitis suppurativa registries
Background: Several registries for hidradenitis suppurativa (HS) already exist in Europe and the USA. There is currently no global consensus on a core dataset (CDS) for these registries. Creating a global HS registry is challenging, owing to logistical and regulatory constraints, which could limit opportunities for global collaboration as a result of differences in the dataset collected. The solution is to encourage all HS registries to collect the same CDS of information, allowing registries to collaborate. Objectives: To establish a core set of items to be collected by all HS registries globally. The core set will cover demographic details, comorbidities, clinical examination findings, patient-reported outcome measures and treatments. Methods: Beginning in September 2022, 20 participants – including both clinicians with expertise in HS and patient advocates – from eight countries across three continents participated in a Delphi process consisting of four rounds of voting, with all participants completing each round. A list of potential items for inclusion in the core set was generated from the relevant published literature, including systematic reviews of comorbidities in HS, clinical and examination findings, and epidemiology. For disease severity and progression items, the Hidradenitis SuppuraTiva Core outcome set International Collaboration (HiSTORIC) core set and other relevant instruments were considered for inclusion. This resulted in 47 initial items. Participants were invited to suggest additional items to include during the first round. Anonymous feedback was provided to inform each subsequent round of voting to encourage consensus. Results: The eDelphi process established a CDS of 48 items recommended for inclusion in all HS registries globally. Conclusions: The routine adoption of this CDS in current and future HS registries should allow registries in different parts of the world to collaborate, enabling research requiring large numbers of participants.
- Open Access
- 4 October 2023
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 23 (1) , 1-7
Teledermatology in an emergency department: benefits and gaps
Background: Teledermatology has provided new avenues through which dermatologists can provide healthcare. Teledermatology was introduced to the Emergency Department (ED) to enable immediate dermatological consult. We aimed to assess the impact of teledermatology on the management of dermatological conditions by emergency medicine physicians and subsequent health resource utilization. Methods: We conducted a retrospective review of teledermatology referrals from the ED of our tertiary hospital in Singapore from June 2015 to December 2019. The dermatological conditions, the triaging and treatment recommendations were analyzed. Follow-up plans were recorded. Results: Between June 2015 and December 2019, 147 patients were referred from the ED via teledermatology; 11 (7.5%) were admitted, and 136 (92.5%) were recommended to be discharged with a dermatological diagnosis and management plan. If required, a follow-up appointment in the dermatology specialist clinic was arranged. Of the 136 patients who were discharged, 129 (94.9%) patients were provided with outpatient appointment in the dermatology clinic, out of which 110 patients returned for follow-up. 90 (81.8%) patients retained the initial teledermatology diagnoses and 20 (18.2%) patients had their teledermatology diagnoses revised after in-person review. Conclusions: Teledermatology allows for more efficient triaging of patients with dermatological conditions. Reliability between teledermatology and clinic-based examination is good. Patients may be managed mainly in the outpatient setting with appropriate specialty-directed treatment, return advice, and appropriately-triaged follow-up outpatient appointment.
- 4 October 2023
- Published by Springer Nature in BMC Emergency Medicine
- Vol. 23 (1) , 1-7
Open AccessTeledermatology in an emergency department: benefits and gaps
Background: Teledermatology has provided new avenues through which dermatologists can provide healthcare. Teledermatology was introduced to the Emergency Department (ED) to enable immediate dermatological consult. We aimed to assess the impact of teledermatology on the management of dermatological conditions by emergency medicine physicians and subsequent health resource utilization. Methods: We conducted a retrospective review of teledermatology referrals from the ED of our tertiary hospital in Singapore from June 2015 to December 2019. The dermatological conditions, the triaging and treatment recommendations were analyzed. Follow-up plans were recorded. Results: Between June 2015 and December 2019, 147 patients were referred from the ED via teledermatology; 11 (7.5%) were admitted, and 136 (92.5%) were recommended to be discharged with a dermatological diagnosis and management plan. If required, a follow-up appointment in the dermatology specialist clinic was arranged. Of the 136 patients who were discharged, 129 (94.9%) patients were provided with outpatient appointment in the dermatology clinic, out of which 110 patients returned for follow-up. 90 (81.8%) patients retained the initial teledermatology diagnoses and 20 (18.2%) patients had their teledermatology diagnoses revised after in-person review. Conclusions: Teledermatology allows for more efficient triaging of patients with dermatological conditions. Reliability between teledermatology and clinic-based examination is good. Patients may be managed mainly in the outpatient setting with appropriate specialty-directed treatment, return advice, and appropriately-triaged follow-up outpatient appointment.
- Open Access
- 6 July 2023
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 6 (1) , e47168
Where Are We With Teledermatology? Two Years in the Wake of COVID-19
- 6 July 2023
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 6 (1) , e47168
Open AccessWhere Are We With Teledermatology? Two Years in the Wake of COVID-19
- Open Access
- 7 April 2023
- Published by Elsevier in JAAD International
- Vol. 12, 72-80
Knowledge, attitudes, and perceptions of hidradenitis suppurativa among young adults in Singapore
- 7 April 2023
- Published by Elsevier in JAAD International
- Vol. 12, 72-80
Open AccessKnowledge, attitudes, and perceptions of hidradenitis suppurativa among young adults in Singapore
- Open Access
- 10 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Where Are We With Teledermatology? Two Years in the Wake of COVID-19 (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Much attention was brought to teledermatology during the COVID-19 pandemic, but how has this trend held up? Two years on, we review the trends of teledermatology in our institute and globally, and discuss the role of teledermatology moving forward. Data from our institution indicated a lower uptake of teledermatology compared to global trends. The number of teleconsults planned increased with coordinated institutional efforts to bolster the use of teledermatology in response to the COVID-19 situation, however, the number of teleconsults conducted remained largely stable between 1%-2% of total consultations. Reasons for declining teledermatology included a perceived lower quality of care, having to pay the same price as a physical consultation and technological barriers. While the increase in accessibility to dermatological care and cost savings of teledermatology may be less pronounced in highly-connected city-states like Singapore, teledermatology plays a salient role in improving service options, flexibility of pivoting to virtual care in times of need, and offering an effective and feasible model of care in various settings.
- 10 March 2023
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessWhere Are We With Teledermatology? Two Years in the Wake of COVID-19 (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Much attention was brought to teledermatology during the COVID-19 pandemic, but how has this trend held up? Two years on, we review the trends of teledermatology in our institute and globally, and discuss the role of teledermatology moving forward. Data from our institution indicated a lower uptake of teledermatology compared to global trends. The number of teleconsults planned increased with coordinated institutional efforts to bolster the use of teledermatology in response to the COVID-19 situation, however, the number of teleconsults conducted remained largely stable between 1%-2% of total consultations. Reasons for declining teledermatology included a perceived lower quality of care, having to pay the same price as a physical consultation and technological barriers. While the increase in accessibility to dermatological care and cost savings of teledermatology may be less pronounced in highly-connected city-states like Singapore, teledermatology plays a salient role in improving service options, flexibility of pivoting to virtual care in times of need, and offering an effective and feasible model of care in various settings.
- Open Access
- 31 January 2023
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 6, e43910
Dermatologists’ Perceptions of the Use of Teledermatology in Managing Hidradenitis Suppurativa: Survey Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The COVID-19 pandemic has led to rapid adoption of teledermatology for the management of both acute and chronic skin disorders. Amongst conditions managed with teledermatology, Hidradenitis Suppurativa (HS) is a chronic inflammatory condition which due the nature of its skin lesions and the sites involved, is perceived to require recurrent clinical evaluation and may be subjected to privacy concerns amongst patients when managed over teledermatology. Objective: We sought to assess dermatologists’ perceptions of and experiences with teledermatology in managing HS. Methods: Participants were invited to completed a survey electronically, via a secure online platform. The survey was disseminated to members of the Asia Pacific Hidradenitis Suppurativa Foundation and through word of mouth, gathering responses over February to June 2022, from participants practicing in the Asia-Pacific region. Data pertaining to demographics and survey responses were collated. Associations between demographics and attitudes towards teledermatology for hidradenitis suppurativa was evaluated by multivariable ordered logistic regression. Attitudes towards teledermatology between hidradenitis suppurativa and atopic dermatitis were compared by random-effects ordered logistic regression, with adjustment for demographics. Results: 100 responses were obtained comprising of 76 (81.7%) dermatologists and 17 dermatology trainees (18.3%). There was equal representation of male and female gender. There was ambivalence amongst physicians regarding comfort and willingness to employ teledermatology for HS patients. Older physicians had increased tendency to express sentiments that it was difficult to accurately assess disease severity for HS, and concerns that patients may not be familiar with using teledermatology for HS. There was an overall increased tendency for physicians to perceive difficulty in managing HS compared to AD (assessed as a control cohort) – in terms of photography of hard-to-reach/sensitive areas (adjusted OR 4.71 (95% confidence interval: 2.44-9.07); p value < 0.001), accurate assessment (adjusted OR 2.66 (95% confidence interval: 1.48-4.79); p value 0.001), privacy issues from examination of private body areas (adjusted OR 2.75 (95% confidence interval 1.36-5.56); p value 0.005). Conclusions: This study, is the first, to our knowledge that assess physician attitudes towards the use of teledermatology in managing HS patients, and compares differential perspectives of its use on HS and AD patients. The findings of this study suggest that teledermatology is overall unsuitable for use in HS, but may be considered and useful in selected settings, for instance, for patients with quiescent or mild HS, patients with less HS involvement in intimate body areas, patients who were more willing to share documentation if required of affected body areas and in patients who already have an established and strong doctor-patient relationship with their HS provider. Physicians’ efforts should be focused on streamlining patient selection and optimizing consult environments for patients with HS. Clinical Trial: NA
- 31 January 2023
- Published by JMIR Publications Inc. in JMIR Dermatology
- Vol. 6, e43910
Open AccessDermatologists’ Perceptions of the Use of Teledermatology in Managing Hidradenitis Suppurativa: Survey Study
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The COVID-19 pandemic has led to rapid adoption of teledermatology for the management of both acute and chronic skin disorders. Amongst conditions managed with teledermatology, Hidradenitis Suppurativa (HS) is a chronic inflammatory condition which due the nature of its skin lesions and the sites involved, is perceived to require recurrent clinical evaluation and may be subjected to privacy concerns amongst patients when managed over teledermatology. Objective: We sought to assess dermatologists’ perceptions of and experiences with teledermatology in managing HS. Methods: Participants were invited to completed a survey electronically, via a secure online platform. The survey was disseminated to members of the Asia Pacific Hidradenitis Suppurativa Foundation and through word of mouth, gathering responses over February to June 2022, from participants practicing in the Asia-Pacific region. Data pertaining to demographics and survey responses were collated. Associations between demographics and attitudes towards teledermatology for hidradenitis suppurativa was evaluated by multivariable ordered logistic regression. Attitudes towards teledermatology between hidradenitis suppurativa and atopic dermatitis were compared by random-effects ordered logistic regression, with adjustment for demographics. Results: 100 responses were obtained comprising of 76 (81.7%) dermatologists and 17 dermatology trainees (18.3%). There was equal representation of male and female gender. There was ambivalence amongst physicians regarding comfort and willingness to employ teledermatology for HS patients. Older physicians had increased tendency to express sentiments that it was difficult to accurately assess disease severity for HS, and concerns that patients may not be familiar with using teledermatology for HS. There was an overall increased tendency for physicians to perceive difficulty in managing HS compared to AD (assessed as a control cohort) – in terms of photography of hard-to-reach/sensitive areas (adjusted OR 4.71 (95% confidence interval: 2.44-9.07); p value < 0.001), accurate assessment (adjusted OR 2.66 (95% confidence interval: 1.48-4.79); p value 0.001), privacy issues from examination of private body areas (adjusted OR 2.75 (95% confidence interval 1.36-5.56); p value 0.005). Conclusions: This study, is the first, to our knowledge that assess physician attitudes towards the use of teledermatology in managing HS patients, and compares differential perspectives of its use on HS and AD patients. The findings of this study suggest that teledermatology is overall unsuitable for use in HS, but may be considered and useful in selected settings, for instance, for patients with quiescent or mild HS, patients with less HS involvement in intimate body areas, patients who were more willing to share documentation if required of affected body areas and in patients who already have an established and strong doctor-patient relationship with their HS provider. Physicians’ efforts should be focused on streamlining patient selection and optimizing consult environments for patients with HS. Clinical Trial: NA
- Open Access
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (4) , 313-317
Impact of Hand Hygiene and Mask-Wearing Practices on Hand Eczema and Facial Acne Incidence in Healthcare Workers during COVID-19 Outbreak
Santosa A, et al. Ann Dermatol. 2023 Jul;35:e101. https://doi.org/10.5021/ad.20.189
- 1 January 2023
- Published by XMLink in Annals of Dermatology
- Vol. 35 (4) , 313-317
Open AccessImpact of Hand Hygiene and Mask-Wearing Practices on Hand Eczema and Facial Acne Incidence in Healthcare Workers during COVID-19 Outbreak
Santosa A, et al. Ann Dermatol. 2023 Jul;35:e101. https://doi.org/10.5021/ad.20.189